Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 19,000 | |||
10 mg | 在庫あり | ¥ 33,500 | |||
25 mg | 在庫あり | ¥ 68,500 | |||
50 mg | 在庫あり | ¥ 122,500 | |||
100 mg | 在庫あり | ¥ 174,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 19,500 |
説明 | BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma. |
In vivo | Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression. |
分子量 | 472.58 |
分子式 | C27H32N6O2 |
CAS No. | 1550371-22-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (21.16 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-P5 free base 1550371-22-6 Chromatin/Epigenetic PAD BMS-P-5 free base BMS P5 free base myeloma Inhibitor inhibit BMS-P5 Protein Arginine Deiminase Multiple NET BMSP5 free base Peptidylarginine Deiminase inhibitor